Trump's Weight-Loss Drug Push May Put These ETFs On A Diet

Benzinga_recent_news

昨天

The weight-loss industry that fueled one of Wall Street’s most popular ETF themes may finally be going on a crash diet. ETFs loaded with exposure to obesity-drug titans Eli Lilly And Co (NYSE:LLY) and...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2576069276"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576069276\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576069276?lang=zh_CN&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/17/Weight-Loss-Drugs.jpeg?optimize=medium&dpr=2&auto=webp&width=120","is_english":true,"pubTime":"2025-10-18 04:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2576069276","market":"us","top_or_hot":-1,"title":"Trump's Weight-Loss Drug Push May Put These ETFs On A Diet","media":"Benzinga_recent_news","content":"<div>\n<p>The weight-loss industry that fueled one of Wall Street’s most popular ETF themes may finally be going on a crash diet.\nETFs loaded with exposure to obesity-drug titans Eli Lilly And Co (NYSE:LLY) and...</p>\n\n<a href=\"https://www.benzinga.com/etfs/sector-etfs/25/10/48287337/trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet\">网页链接</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trump's Weight-Loss Drug Push May Put These ETFs On A Diet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrump's Weight-Loss Drug Push May Put These ETFs On A Diet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-18 04:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/etfs/sector-etfs/25/10/48287337/trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The weight-loss industry that fueled one of Wall Street’s most popular ETF themes may finally be going on a crash diet.\nETFs loaded with exposure to obesity-drug titans Eli Lilly And Co (NYSE:LLY) and...</p>\n\n<a href=\"https://www.benzinga.com/etfs/sector-etfs/25/10/48287337/trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABU","symbol_name":"三倍做多标普生物-Direxion","start_time":0,"source_url":"https://www.benzinga.com/etfs/sector-etfs/25/10/48287337/trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet","article_id":"2576069276","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/17/Weight-Loss-Drugs.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/sector-etfs/25/10/48287337/trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2576069276","pubTimestamp":1760731980,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LABU":"三倍做多标普生物-Direxion","IYH":"iShares U.S. Healthcare ETF","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LLY":"礼来","LU2360106947.USD":"BGF NUTRITION \"A4\" (USD) INC","XBI":"SPDR S&P Biotech ETF","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","NVO":"诺和诺德","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1232071149.USD":"AZ FUND 1 GLOBAL GROWTH SELECTOR \"AAZ\" (USDHDG) ACC","HIMS":"Hims & Hers Health Inc.","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","HEAL":"Global X HealthTech ETF","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","BK4516":"特朗普概念","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","XLV":"健康照护类股ETF-SPDR","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0471298694.HKD":"BGF NUTRITION \"A2\" (HKD) ACC","SG9999014906.USD":"大华全球优质成长基金Acc USD","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","FDN":"First Trust Dow Jones Internet I","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","BK4007":"制药","LU0122379950.USD":"贝莱德世界健康科学A2"},"translate_title":"特朗普的减肥药推广可能会让这些ETF节食","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FDN":0.9,"HEAL":1,"HIMS":1,"IYH":1,"LABU":0.6,"LLY":1,"NVO":1,"XBI":0.6,"XLV":0.73},"content_text":"The weight-loss industry that fueled one of Wall Street’s most popular ETF themes may finally be going on a crash diet.\nETFs loaded with exposure to obesity-drug titans Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are tottering after President Donald Trump pledged to reduce the price of top-selling GLP-1 medication such as Ozempic and Zepbound — the same names that drove pharma portfolios to all-time highs. Both stocks are down around 3% on Friday.\n    • LLY is among today’s weakest performers. See the trading setup here.\nHims & Hers Health Inc (NYSE:HIMS), a company that sells compounded forms of these medications, plummeted more than 15% on Friday, highlighting just how tenuous the GLP-1 universe has grown. Trump’s comments, coupled with Hims & Hers’ own CEO’s stock sale and latest menopause-treatment launch, have investors wondering if the formerly bulletproof “weight-loss economy” can keep its stride going.\nThe VanEck Pharmaceutical ETF (NASDAQ:PPH) and the iShares U.S. Healthcare ETF (IYH), both heavily exposed to Lilly and Novo Nordisk, may experience near-term volatility if price reductions pinch margins. \nAthough the ETFs are not reflecting the stocks’ declines yet, both of these ETFs prospered as the obesity-drug frenzy pushed valuations to dizzying heights, and the industry faces a reality check if drug profits thin out at a faster rate than patients.\nDigital-health–focused funds are also taking a hit. The iShares Healthcare Innovation ETF (NASDAQ:HEAL) and the ROBO Global Healthcare Technology and Innovation ETF (NYSE:HTEC) are down around 1% each, reflecting broader weakness in telemedicine and health-tech names. While neither fund directly holds Hims & Hers, Novo or Lilly, both mirror the sentiment.\nOn the speculative front, the ARK Genomic Revolution ETF (BATS:ARKG), which is down 3% on Friday, provides exposure to next-generation biotechs developing novel obesity and metabolic therapies, future incumbents to the GLP-1 behemoths.\nThe GLP-1 saga is changing. What started as a simple wager on miracle pills has grown into a multifaceted game of regulation, pricing and public policy. ETF investors who feasted on the obesity-trade profits of 2023–’24 now get to face their first big test: if the sector’s expansion is sustainable when politics go on the prescription pad.\nFor the moment, the Ozempic trade just became political, and ETF investors might need to begin counting calories in their health care portfolios.\nRead Next: \nPhoto: Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}